Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T05:59:07.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-04-23T22:53:13.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed information about the interventional model for a clinical trial involving pembrolizumab and cetuximab for head and neck cancer, as well as the revision of the document version. Notably, the previous version's detailed trial description and objectives have been removed.
    Difference
    35%
    Check dated 2025-04-16T16:43:29.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v2.14.4, replacing the previous version v2.14.3.
    Difference
    0.2%
    Check dated 2025-04-09T11:04:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has updated the status of a clinical trial to 'Unknown' and revised the version number from v2.14.2 to v2.14.3. Additionally, the verification date and the name of the verifying physician have been added.
    Difference
    0.7%
    Check dated 2025-04-01T23:45:42.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T22:40:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.